| Revenue | DKK 5,4M | -27% |
| EBITDA | DKK -2,7M | -221% |
| Net profit | DKK -2,9M | -275% |
| Total assets | DKK 6,5M | +17% |
| Equity | DKK -969K | -149% |
| Employees | 9 | — |
| Item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | 750 | 7.434 | 5.414 |
| Staff expenses | -810 | -5.208 | -8.103 |
| EBITDA | -60 | 2.226 | -2.689 |
| Depreciation & amort. | -0 | -176 | -176 |
| EBIT | -60 | 2.050 | -2.865 |
| Net financials | 60 | 78 | -598 |
| Profit before tax | 0 | 2.128 | -3.463 |
| Tax | 110 | 454 | -530 |
| Net profit | -110 | 1.674 | -2.933 |
| Item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Total assets | 13.693 | 5.517 | 6.464 |
| Equity | 290 | 1.964 | -969 |
| Long-term debt | 0 | 0 | 0 |
| Short-term debt | 13.403 | 3.553 | 7.433 |
| Total debt | 13.403 | 3.553 | 7.433 |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
JB Chief Executive Officer | Chief Executive Officer | 2023 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2023 | — | — | |
| Board of Directors | 2023 | — | — | |
| Chairman | 2023 | — | — | |
| Board of Directors | 2023 | — | — | |
| Board of Directors | 2023 | — | — | |
| Deputy Chairman | 2023 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
BioInnovation Institute Fonden | Company | 100.0% | 100.0% | 2023 |
| Person | Role here | Other companies |
|---|---|---|
| Jens Bredal Nielsen | Chief Executive Officer | 0 companies |
| Mads Krogsgaard Thomsen | Board of Directors | 0 companies |
| Martin Bonde | Board of Directors | 0 companies |
| Marianne Philip | Chairman | 0 companies |
| Hans Thalsgård Schambye | Board of Directors | 0 companies |
| Regina Hodits | Board of Directors | 0 companies |
| Robert Glen Urban | Deputy Chairman | 0 companies |